Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipta Sarana Medika Tbk. (DKHH) vs Suparma Tbk. (SPMA) Price & Performance

Cipta Sarana Medika Tbk.Trade
Suparma Tbk.Trade

Price performance (Past 24H)

Key statistics

Cipta Sarana Medika Tbk. vs Suparma Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume), while Suparma Tbk. trades at Rp164 (market cap 879.52B, 89.4K 24h volume). The key difference: Suparma Tbk. is far larger — about 5.5× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (14.05M versus 89.4K). Which is the better fit depends on your goals.

DKHHSPMA
Market Cap
160.67B879.52B
Volume
14.05M89.4K
Lot
140.49K894
Turnover
899.67M14.68M
Average Price
64.04164.16
Value
899.67M14.68M
Indicative Equilibrium Price
64164
Indicative Equilibrium Volume
10012

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKHH
View details
SPMA
View details

About Cipta Sarana Medika Tbk.

PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.

Read more on DKHH

About Suparma Tbk.

PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.

Read more on SPMA